about
International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cellsMTNR1B G24E variant associates With BMI and fasting plasma glucose in the general population in studies of 22,142 EuropeansMelatonergic drugs in development.Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.Differences in daily rhythms of wrist temperature between obese and normal-weight women: associations with metabolic syndrome featuresSocial Ecology, Genomics, and African American Health: A Nonlinear Dynamical PerspectiveCirculating melatonin and the risk of breast and endometrial cancer in women.Investigational melatonin receptor agonists.Nanotherapeutics for Alzheimer's disease (AD): Past, present and future.Melatonin and the metabolic syndrome: a tool for effective therapy in obesity-associated abnormalities?The antioxidative property of melatonin against brain ischemia.Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers.5-Meth-oxy-2-[(5-meth-oxy-1H-indol-1-yl)carbon-yl]-1H-indole.MT1-selective melatonin receptor ligands: synthesis, pharmacological evaluation, and molecular dynamics investigation of N-{[(3-O-substituted)anilino]alkyl}amides.Melatonin potentiates glycine currents through a PLC/PKC signalling pathway in rat retinal ganglion cells.Synthesis and in vitro evaluation of melatonin entrapped PLA nanoparticles: an oxidative stress and T-cell response using golden hamster.Circadian Rhythms in Diet-Induced Obesity.Facile and novel synthesis of palladium nanoparticles supported on a carbon aerogel for ultrasensitive electrochemical sensing of biomolecules.A circadian rhythm-related MTNR1B genetic variant modulates the effect of weight-loss diets on changes in adiposity and body composition: the POUNDS Lost trial.Melatonin Modulation of Sirtuin-1 Attenuates Liver Injury in a Hypercholesterolemic Mouse Model.
P2860
Q24623433-9C575020-0002-4456-B7D9-1AFA9C7EE7FBQ28385402-CAE2594B-E0BE-429A-AFCF-A63C1044879DQ33869843-2626CEC4-CF16-4DD6-B5E1-E41DB9D488B4Q34440574-259D5C40-C860-4F48-954E-09217D71596BQ35015993-5B436C6B-D130-4541-BEDE-771AD5E2DB54Q35213704-B1B5960F-9FF0-4E61-B62D-9E094531C5DCQ37297344-4EBABACF-663F-4317-9329-0D13B6A0196EQ37328085-A7EDD940-E0E4-4D4A-8DE8-EC8EEDB4168FQ37735169-8B2470D9-EBC2-47FD-B83E-35CEE2CD0C08Q37948993-1F3DE2EF-93BC-4EF1-B9DE-6FBFBB1455AFQ37973897-C706DEE6-D19F-4925-8743-EE982ED6451BQ38816026-994A1CF9-1D92-42FF-AF2F-C31EF250B731Q41103172-7C225E73-58AB-455A-82C1-39B2684CFA90Q42144058-CC1529EF-992B-438F-A57A-40C141859025Q42716227-19662742-4537-4B73-84E9-5C7EE636DAF0Q43046164-18F2AB65-A2E7-44BE-9888-1A6DED203EB3Q46766118-FD289515-C5CF-4453-8786-893512672666Q50599434-3BDBDB4E-A6EA-4281-85C7-FBE2CFEB3739Q50891393-D39D5642-3C03-47C9-AC39-AF3356D8647FQ52667791-23B44B9C-0DB6-4D87-8B86-9CEBF9CB9275Q52667957-22F69FAE-3014-41CE-A166-5A567455A6DF
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Physiological and metabolic functions of melatonin.
@ast
Physiological and metabolic functions of melatonin.
@en
type
label
Physiological and metabolic functions of melatonin.
@ast
Physiological and metabolic functions of melatonin.
@en
prefLabel
Physiological and metabolic functions of melatonin.
@ast
Physiological and metabolic functions of melatonin.
@en
P2093
P356
P1476
Physiological and metabolic functions of melatonin.
@en
P2093
Barrenetxe J
Delagrange P
Martínez JA
P2860
P2888
P356
10.1007/BF03168221
P577
2004-03-01T00:00:00Z